Landegger, Lukas D http://orcid.org/0000-0002-9660-2625
Pan, Bifeng http://orcid.org/0000-0001-9746-3420
Askew, Charles http://orcid.org/0000-0002-6131-6602
Wassmer, Sarah J
Gluck, Sarah D
Galvin, Alice
Taylor, Ruth
Forge, Andrew
Stankovic, Konstantina M
Holt, Jeffrey R
Vandenberghe, Luk H http://orcid.org/0000-0002-3508-4924
Article History
Received: 26 February 2016
Accepted: 4 January 2017
First Online: 6 February 2017
Competing interests
: L.H.V. holds founder equity in GenSight Biologics, is a consultant to a number of biotech and pharmaceutical companies, and is an inventor on gene therapy patents, including Anc80L65, which are licensed to various entities. L.H.V. also receives sponsored research from Lonza Houston and Selecta Biosciences, licensees of Anc80L65. L.H.V., K.M.S., and J.R.H. have filed a patent on the use of Anc80L65 in the cochlea.